Patient-centered care in immuno-oncology: current progress & opportunities when considering safety & tolerability

Immuno-Oncology Insights 2022; 3(6), 305–310

DOI: 10.18609/ioi.2022.029

Published: 24 May 2022
Commentary
Céline Adessi, Dominik Rüttinger

Patient centricity has previously been defined as “putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family” [1] or more succinctly: “No decision about me, without me”. But what does patient centricity look like in practice, and what benefits can it bring – both to the patient themselves and to other stakeholders in the cancer immunotherapy space?